Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Arcucci, Alessandro ^a   Ruocco, Maria Rosaria ^a   Granato, Giuseppina ^a   Sacco, Anna Maria ^a   Montagnani, Stefania ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER GROWTH; CELL ACTIVATION; CELL INTERACTION; HOMEOSTASIS; HUMAN; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; STROMA CELL; TUMOR MICROENVIRONMENT; CELL COMMUNICATION; CELL DIFFERENTIATION; FIBROBLAST; METABOLISM; MYOFIBROBLAST; NEOPLASM; OXIDATION REDUCTION REACTION; PATHOLOGY;

CELL COMMUNICATION; CELL DIFFERENTIATION; FIBROBLASTS; HUMANS; MYOFIBROBLASTS; NEOPLASMS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84984685578     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/4502846     Document Type: Review

References (83)

1. V. Gkretsi, A. Stylianou, P. Papageorgis, C. Polydorou, and T. Stylianopoulos, "Remodeling components of the tumor microenvironment to enhance cancer therapy, " Frontiers in Oncology, vol. 5, article 214, 2015.
2. A. Alphonso and S. K. Alahari, "Stromal cells and integrins: conforming to the needs of the tumor microenvironment, " Neoplasia, vol. 11, no. 12, pp. 1264-1271, 2009.
3. S. H. Lee, D. Jeong, Y. Han, and M. J. Baek, "Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis, " Annals of Surgical Treatment and Research, vol. 89, no. 1, pp. 1-8, 2015.
4. X. Guan, "Cancer metastases: challenges and opportunities, " Acta Pharmaceutica Sinica B, vol. 5, no. 5, pp. 402-418, 2015.
5. S. Madar, I. Goldstein, and V. Rotter, "'Cancer associated fibroblasts'-more than meets the eye, " Trends in Molecular Medicine, vol. 19, no. 8, pp. 447-453, 2013.
6. D. Öhlund, E. Elyada, and D. Tuveson, "Fibroblast heterogeneity in the cancer wound, "The Journal of ExperimentalMedicine, vol. 211, no. 8, pp. 1503-1523, 2014.
7. P. Gascard and T. D. Tlsty, "Carcinoma-associated fibroblasts: orchestrating the composition of malignancy, " Genes & Development, vol. 30, no. 9, pp. 1002-1019, 2016.
8. A.-P. Sappino, O. Skalli, B. Jackson, W. Schürch, and G. Gabbiani, "Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues, " International Journal of Cancer, vol. 41, no. 5, pp. 707-712, 1988.
9. A. Orimo and R. A. Weinberg, "Heterogeneity of stromal fibroblasts in tumors, " Cancer Biology & Therapy, vol. 6, no. 4, pp. 618-619, 2007.
10. B. Hinz, S. H. Phan, V. J. Thannickal et al., "Recent developments inmyofibroblast biology: paradigms for connective tissue remodeling, " The American Journal of Pathology, vol. 180, no. 4, pp. 1340-1355, 2012.
11. A. Neesse, P. Michl, K. K. Frese et al., "Stromal biology and therapy in pancreatic cancer, " Gut, vol. 60, no. 6, pp. 861-868, 2011.
12. Y. A. DeClerck, "Desmoplasia: a response or a niche" Cancer Discovery, vol. 2, no. 9, pp. 772-774, 2012.
13. C. Scheuba, K. Kaserer, K. Kaczirek, R. Asari, and B. Niederle, "Desmoplastic stromal reaction in medullary thyroid cancer- an intraoperative 'marker' for lymph node metastases, " World Journal of Surgery, vol. 30, no. 5, pp. 853-859, 2006.
14. O. Koperek, R. Asari, B. Niederle, and K. Kaserer, "Desmoplastic stromal reaction in papillary thyroid microcarcinoma, " Histopathology, vol. 58, no. 6, pp. 919-924, 2011.
15. R. K. Jain, J. D. Martin, and T. Stylianopoulos, "The role of mechanical forces in tumor growth and therapy, "Annual Review of Biomedical Engineering, vol. 16, pp. 321-346, 2014.
16. A. Costa, A. Scholer-Dahirel, and F. Mechta-Grigoriou, "The role of reactive oxygen species and metabolism on cancer cells and their microenvironment, " Seminars in Cancer Biology, vol. 25, pp. 23-32, 2014.
17. A. Jezierska-Drutel, S. A. Rosenzweig, and C. A. Neumann, "Role of oxidative stress and the microenvironment in breast cancer development and progression, " Advances in Cancer Research, vol. 119, pp. 107-125, 2013.
18. S. Prasad, S. C. Gupta, and A. K. Tyagi, "Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals, " Cancer Letters, vol. 3835, no. 16, pp. 30202-30206, 2016.
19. E. Gammella, S. Recalcati, and G. Cairo, "Dual role of ROS as signal and stress agents: iron tips the balance in favor of toxic effects, " Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 8629024, 9 pages, 2016.
20. F. Albano, A. Arcucci, G. Granato et al., "Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines, " Biochimie, vol. 95, no. 4, pp. 934-945, 2013.
21. F. Hecht, C. F. Pessoa, L. B. Gentile, D. Rosenthal, D. P. Carvalho, and R. S. Fortunato, "The role of oxidative stress on breast cancer development and therapy, " Tumor Biology, vol. 37, no. 4, pp. 4281-4291, 2016.
22. L. Enns and W. Ladiges, "Mitochondrial redox signaling and cancer invasiveness, " Journal of Bioenergetics and Biomembranes, vol. 44, no. 6, pp. 635-638, 2012.
23. G. P. Bienert, A. L. B. Møller, K. A. Kristiansen et al., "Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes, "The Journal of Biological Chemistry, vol. 282, no. 2, pp. 1183-1192, 2007.
24. M. J. Marchissio, D. E. A. Francés, C. E. Carnovale, and R. A. Marinelli, "Mitochondrial aquaporin-8 knockdown in human hepatoma HepG2 cells causes ROS-induced mitochondrial depolarization and loss of viability, " Toxicology and Applied Pharmacology, vol. 264, no. 2, pp. 246-254, 2012.
25. H. Chang, Y.-H. Shi, T.-K. Talaf, and C. Lin, "Aquaporin-8 mediates human esophageal cancer Eca-109 cell migration via the EGFR-Erk1/2 pathway, " International Journal of Clinical and Experimental Pathology, vol. 7, no. 11, pp. 7663-7671, 2014.
26. H. Chang, Y. Shi, T. Tuokan, R. Chen, and X. Wang, "Expression of aquaporin 8 and phosphorylation of Erk1/2 in cervical epithelial carcinogenesis: correlation with clinicopathological parameters, " International Journal of Clinical and Experimental Pathology, vol. 7, no. 7, pp. 3928-3937, 2014.
27. S.-J. Zhu, K.-J. Wang, S.-W. Gan, J. Xu, S.-Y. Xu, and S.-Q. Sun, "Expression of aquaporin8 in human astrocytomas: correlation with pathologic grade, " Biochemical and Biophysical Research Communications, vol. 440, no. 1, pp. 168-172, 2013.
28. F. Vieceli Dalla Sega, L. Zambonin, D. Fiorentini et al., "Specific aquaporins facilitate Nox-produced hydrogen peroxide transport through plasma membrane in leukaemia cells, " Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol. 1843, no. 4, pp. 806-814, 2014.
29. K. Pietras and A. Östman, "Hallmarks of cancer: interactions with the tumor stroma, " Experimental Cell Research, vol. 316, no. 8, pp. 1324-1331, 2010.
30. E. S. Radisky and D. C. Radisky, "Stromal induction of breast cancer: inflammation and invasion, " Reviews in Endocrine and Metabolic Disorders, vol. 8, no. 3, pp. 279-287, 2007.
31. J. Zavadil, J. Haley, R. Kalluri, S. K. Muthuswamy, and E. Thompson, "Epithelial-mesenchymal transition, " Cancer Research, vol. 68, no. 23, pp. 9574-9577, 2008.
32. E. M. Zeisberg, S. Potenta, L. Xie, M. Zeisberg, and R. Kalluri, "Discovery of endothelial tomesenchymal transition as a source for carcinoma-associated fibroblasts, " Cancer Research, vol. 67, no. 21, pp. 10123-10128, 2007.
33. L. T. McDonald, D. L. Russell, R. R. Kelly et al., "Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment, " Neoplasia, vol. 17, no. 5, pp. 434-448, 2015.
34. B. Dirat, L. Bochet, M. Dabek et al., "Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion, " Cancer Research, vol. 71, no. 7, pp. 2455-2465, 2011.
35. Y. Kojima, A. Acar, E. N. Eaton et al., "Autocrine TGF- and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 46, pp. 20009-20014, 2010.
36. L. Mueller, F. A. Goumas, M. Affeldt et al., "Stromal fibroblasts in colorectal livermetastases originate from resident fibroblasts and generate an inflammatory microenvironment, " The American Journal of Pathology, vol. 171, no. 5, pp. 1608-1618, 2007.
37. M. Augsten, "Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment, " Frontiers in Oncology, vol. 4, article 62, Article IDArticle 62, 2014.
38. K. Shiga, M. Hara, T. Nagasaki, T. Sato, H. Takahashi, and H. Takeyama, "Cancer-associated fibroblasts: their characteristics and their roles in tumor growth, " Cancers, vol. 7, no. 4, pp. 2443-2458, 2015.
39. R. J. Buchsbaum and S. Y. Oh, "Breast cancer-associated fibroblasts: where we are and where we need to go, " Cancers, vol. 8, no. 2, article 19, 2016.
40. V. Catalano, A. Turdo, S. Di Franco, F. Dieli, M. Todaro, and G. Stassi, "Tumor and its microenvironment: a synergistic interplay, " Seminars in Cancer Biology, vol. 23, no. 6, pp. 522-532, 2013.
41. L. Alili, M. Sack, K. Puschmann, and P. Brenneisen, "Fibroblastto-myofibroblast switch is mediated by NAD(P)H oxidase generated reactive oxygen species, " Bioscience Reports, vol. 34, no. 1, Article IDe00089, 2014.
42. E. Crosas-Molist, E. Bertran, and I. Fabregat, "Cross-talk between TGF- and NADPH oxidases during liver fibrosis and hepatocarcinogenesis, " Current Pharmaceutical Design, vol. 21, no. 41, pp. 5964-5976, 2015.
43. L. Hecker, R. Vittal, T. Jones et al., "NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury, " Nature Medicine, vol. 15, no. 9, pp. 1077-1081, 2009.
44. N. Amara, D. Goven, F. Prost, R. Muloway, B. Crestani, and J. Boczkowski, "NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGF 1-induced fibroblast differentiation into myofibroblasts, " Thorax, vol. 65, no. 8, pp. 733-738, 2010.
45. I. Cucoranu, R. Clempus, A. Dikalova et al., "NAD(P)Hoxidase 4 mediates transforming growth factor- 1-induced differentiation of cardiac fibroblasts into myofibroblasts, " Circulation Research, vol. 97, no. 9, pp. 900-907, 2005.
46. M. Jain, S. Rivera, E. A. Monclus et al., "Mitochondrial reactive oxygen species regulate transforming growth factor- signaling, " TheJournal of Biological Chemistry, vol. 288, no. 2, pp. 770-777, 2013.
47. R. Samarakoon, J. M. Overstreet, and P. J. Higgins, "TGF- signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities, " Cellular Signalling, vol. 25, no. 1, pp. 264-268, 2013.
48. M. L. Taddei, E. Giannoni, G. Raugei et al., "Mitochondrial oxidative stress due to complex I dysfunction promotes fibroblast activation and melanoma cell invasiveness, " Journal of Signal Transduction, vol. 2012, Article ID684592, 10 pages, 2012.
49. A. Toullec, D. Gerald, G. Despouy et al., "Oxidative stress promotes myofibroblast differentiation and tumour spreading, " EMBO Molecular Medicine, vol. 2, no. 6, pp. 211-230, 2010.
50. D. Gerald, E. Berra, Y. M. Frapart et al., "JunD reduces tumor angiogenesis by protecting cells from oxidative stress, " Cell, vol. 118, no. 6, pp. 781-794, 2004.
51. C. Trimmer, F. Sotgia, D. Whitaker-Menezes et al., "Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts, " Cancer Biology andTherapy, vol. 11, no. 4, pp. 383-394, 2011.
52. N. Sampson, R. Koziel, C. Zenzmaier et al., "ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma, "Molecular Endocrinology, vol. 25, no. 3, pp. 503-515, 2011.
53. D. Xu, I. I. Rovira, and T. Finkel, "Oxidants painting the cysteine chapel: redox regulation of PTPs, " Developmental Cell, vol. 2, no. 3, pp. 251-252, 2002.
54. T.-C. Meng, T. Fukada, and N. K. Tonks, "Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo, " Molecular Cell, vol. 9, no. 2, pp. 387-399, 2002.
55. P. Sharma, R. Chakraborty, L. Wang et al., "Redox regulation of interleukin-4 signaling, " Immunity, vol. 29, no. 4, pp. 551-564, 2008.
56. R. F. Wu, Y. C. Xu, Z. Ma, F. E. Nwariaku, G. A. Sarosi Jr., and L. S. Terada, "Subcellular targeting of oxidants during endothelial cell migration, " The Journal of Cell Biology, vol. 171, no. 5, pp. 893-904, 2005.
57. K. Chen, M. T. Kirber, H. Xiao, Y. Yang, and J. F. Keaney Jr., "Regulation of ROS signal transduction by NADPH oxidase 4 localization, "The Journal of Cell Biology, vol. 181, no. 7, pp. 1129-1139, 2008.
58. J. Frijhoff, M. Dagnell, M. Augsten, E. Beltrami, M. Giorgio, and A. Östman, "The mitochondrial reactive oxygen species regulator p66Shc controls PDGF-induced signaling and migration through protein tyrosine phosphatase oxidation, " Free Radical Biology and Medicine, vol. 68, pp. 268-277, 2014.
59. S. Luanpitpong, S. J. Talbott, Y. Rojanasakul et al., "Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1, "The Journal of Biological Chemistry, vol. 285, no. 50, pp. 38832-38840, 2010.
60. L. Yu, X. Chen, L. Wang, and S. Chen, "Thesweet trap in tumors: aerobic glycolysis and potential targets for therapy, " Oncotarget, vol. 7, no. 25, pp. 38908-38926, 2016.
61. N. S. Chandel, D. S. McClintock, C. E. Feliciano et al., "Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1 during hypoxia: amechanismofO2 sensing, "The Journal of Biological Chemistry, vol. 275, no. 33, pp. 25130-25138, 2000.
62. L. Zhao, Y. Mao, Y. Zhao, Y. Cao, and X. Chen, "Role of multifaceted regulators in cancer glucose metabolism and their clinical significance, " Oncotarget, vol. 7, no. 21, pp. 31572-31585, 2016.
63. G. L. Semenza, "HIF-1 mediates metabolic responses to intratumoral hypoxia andoncogenicmutations, "The Journal of Clinical Investigation, vol. 123, no. 9, pp. 3664-3671, 2013.
64. T. P. Szatrowski and C. F. Nathan, "Production of large amounts of hydrogen peroxide by human tumor cells, " Cancer Research, vol. 51, no. 3, pp. 794-798, 1991.
65. U. E. Martinez-Outschoorn, Z. Lin, C. Trimmer et al., "Cancer cells metabolically 'fertilize' the tumor microenvironment with hydrogen peroxide, driving theWarburg effect: Implications for PET imaging of human tumors, " Cell Cycle, vol. 10, no. 15, pp. 2504-2520, 2011.
66. U. E. Martinez-Outschoorn, S. Pavlides, D. Whitaker-Menezes et al., "Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors, " Cell Cycle, vol. 9, no. 12, pp. 2423-2433, 2014.
67. C. Guido, D. Whitaker-Menezes, C. Capparelli et al., "Metabolic reprogramming of cancer-associated fibroblasts by TGF- drives tumor growth: connecting TGF- signaling with 'Warburg-like' cancer metabolism and L-lactate production, " Cell Cycle, vol. 11, no. 16, pp. 3019-3035, 2012.
68. T. Shan, H. Lu, H. Ji et al., "Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer, " PLoS ONE, vol. 9, no. 6, Article ID e97239, 2014.
69. A. K. Witkiewicz, A. Dasgupta, F. Sotgia et al., "An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers, " The American Journal of Pathology, vol. 174, no. 6, pp. 2023-2034, 2009.
70. P. U. Le, G. Guay, Y. Altschuler, and I. R. Nabi, "Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum, " The Journal of Biological Chemistry, vol. 277, no. 5, pp. 3371-3379, 2002.
71. T.-K. Ha, N.-G. Her, M.-G. Lee et al., "Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulatingHMGA1-mediated GLUT3 transcription, " Cancer Research, vol. 72, no. 16, pp. 4097-4109, 2012.
72. R. Gupta, C. Toufaily, and B. Annabi, "Caveolin and cavin family members: dual roles in cancer, " Biochimie, vol. 107, pp. 188-202, 2014.
73. F. Chen, S. Barman, Y. Yu et al., "Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species, " Free Radical Biology & Medicine, vol. 73, pp. 201-213, 2014.
74. D. Whitaker-Menezes, U. E. Martinez-Outschoorn, Z. Lin et al., "Evidence for a stromal-epithelial 'lactate shuttle' in human tumors: MCT4 is a marker of oxidative stress in cancerassociated fibroblasts, " Cell Cycle, vol. 10, no. 11, pp. 1772-1783, 2011.
75. U. E. Martinez-Outschoorn, F. Sotgia, and M. P. Lisanti, "Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function, " Seminars in Oncology, vol. 41, no. 2, pp. 195-216, 2014.
76. S. Pavlides, D. Whitaker-Menezes, R. Castello-Cros et al., "The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma, " Cell Cycle, vol. 8, no. 23, pp. 3984-4001, 2009.
77. G. Bonuccelli, A. Tsirigos, D. Whitaker-Menezes et al., "Ketones and lactate 'fuel' tumor growth and metastasis: evidence that epithelial cancer cells use oxidativemitochondrial metabolism, " Cell Cycle, vol. 9, no. 17, pp. 3506-3514, 2010.
78. U. E. Martinez-Outschoorn, R. G. Pestell, A. Howell et al., "Energy transfer in 'parasitic' cancer metabolism:mitochondria are the powerhouse and Achilles' heel of tumor cells, " Cell Cycle, vol. 10, no. 24, pp. 4208-4216, 2011.
79. G. Migneco, D. Whitaker-Menezes, B. Chiavarina et al., "Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling, " Cell Cycle, vol. 9, no. 12, pp. 2412-2422, 2010.
80. M. Peiris-Pagès, F. Sotgia, and M. Lisanti, "Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells, " Oncotarget, vol. 6, no. 13, pp. 10728-10745, 2015.
81. E. Piskounova, M. Agathocleous, M. M. Murphy et al., "Oxidative stress inhibits distantmetastasis by human melanoma cells, " Nature, vol. 527, no. 7577, pp. 186-191, 2015.
82. Y. Liu, Q. Li, L. Zhou et al., "Cancer drug resistance: redox resetting renders a way, " Oncotarget, vol. 7, no. 27, pp. 42740-42761, 2016.
83. H. Yan, B.-Y. Guo, and S. Zhang, "Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling, " Biochemical and Biophysical Research Communications, vol. 470, no. 4, pp. 947-954, 2016.